Log in
Lost password
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  News


Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Central Bank of the Republic of China (Taiwan) : Financial Conditions (October 2013)

11/25/2013 | 06:49am US/Eastern
Press Releases

Central Bank of the Republic of China (Taiwan)
PRESS RELEASE Release Date: November 25, 2013

Financial Conditions (October 2013)
Monetary Aggregates For the month of October 2013, the monthly growth rates of the monetary aggregates M1B and M2, measured on a daily average basis, were -0.17% and 0.17%, respectively, both lower than those of last month. The annual growth rates of M1B and M2 increased to 8.58% and 5.99%, respectively, mainly owing to net foreign capital inflows. For the first ten months of this year, the average annual growth rates of M1B and M2 were 6.99% and 4.55%, respectively.
Direct and Indirect Finance At the end of October, the monthly growth rate of total outstanding loans and investments (measured on a cost basis) of monetary financial institutions was 0.28%, lower than that at the end of the previous month. Meanwhile, the annual growth rate decreased from 5.87% at the end of the previous month to 5.53%, mainly owing to slower growth in bank claims on the government and government enterprises. If (1) loans and investments extended by life insurance companies, (2) non-accrual loans reclassified and bad loans written off by monetary financial institutions, and (3) funds raised directly from capital markets were all taken into account, the total outstanding amount of funds raised by the non-financial sector would show an annual growth rate of 5.00%, lower than the 5.06% registered at the end of the previous month.

Notes: 1. The next Financial Conditions (November 2013) is scheduled for release at 16:20 on December 25, 2013.
2. For the release schedule for the coming months, please check the CBC website at
http://www.cbc.gov.tw/ct.asp?xItem=30164&ctNode=515&mp=2 .

Attachment List
React to this article
Latest news
Date Title
05:03p HEALTHCARE REALTY : Announces Third Quarter Earnings Release Date And Conference Call
05:03p WHOLE FOODS MARKET : BRIEF: Glastonbury Police Seeking Man Who Stole Shrimp From Whole Foods
05:03p MOODY : Alaska to be hit by Shell's decision to halt oil exploration - Moody's
05:03p COMPUTER SCIENCES : CSC : Enters into Five-Week Due Diligence Process to Acquire UXC Limited
05:02p INGENIA COMMUNITIES : 1st ADD- Dubai to be a disability-friendly city by 2020
05:02p INGENIA COMMUNITIES : Dubai to be a disability-friendly city by 2020
05:02p DUNKIN BRANDS : Police, Community React To Dunkin' Donuts Worker's Controversial Comment
05:02p GREATBATCH : Results of Operations and Financial Condition, Regulation FD Disclosure (form 8-K)
05:02p ROLLINS : Other Events (form 8-K)
05:02p FMC TECHNOLOGIES : Kay Priestly Appointed to FMC Technologies Board of Directors
Latest news
Hot News 
CLOUDBUY : Appointment of NOMAD and Broker and Restoration to Trading on AIM
MAX PETROLEUM : Shares Cancelled From AIM Amid Financial Uncertainty (ALLISS)
UBS : Start of renovation of UBS's head office and opening of a new, temporary branch
CONTRAVIR PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8-K)
Most Read News
01:05a After Mandatory Tender Offer Renova will own 62,86% of Sulzer AG
01:58p Oil gains as Russia set to meet with producers; stock markets up
10/04DJTrans-Pacific Partnership Trade Deal Within Reach
09:45a ELEMICA : Adds Presentation on "The Epidemic of That's How We've Always Done It" to Supply Chain Conference
09:44a RESEARCH AND MARKETS : Global Neisseria Gonorrhoeae Infections Pipeline Review 2015 - 10 Companies & 16 Drug Profiles
Most recommended articles
05:01pDJGRAIN HIGHLIGHTS : Top Stories of the Day
05:00p Shell's decision to halt oil exploration: Moody's (Alaska to be hit by Shell decision to halt oil exploration)
05:00p Upbeat RBA to Fuel AUD/USD Advance; 0.7220-40 Resistance in Focus
04:58p Pacific trade deal adds to U.S. price quandary for biotech drugs
04:57p DuPont CEO Ellen Kullman to retire